PHASE 1 CLINICAL TRIALS UNITS FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES: EVALUATION OF THERAPEUTICS FOR NEISSERIA GONORRHOEAE

Information

  • Research Project
  • 9567727
  • ApplicationId
    9567727
  • Core Project Number
    N01AI000000
  • Full Project Number
    272201500005I-0-27200006-1
  • Serial Number
  • FOA Number
  • Sub Project Id
  • Project Start Date
    12/15/2014 - 10 years ago
  • Project End Date
    12/14/2021 - 3 years ago
  • Program Officer Name
  • Budget Start Date
    -
  • Budget End Date
    -
  • Fiscal Year
    2017
  • Support Year
  • Suffix
  • Award Notice Date
    -

PHASE 1 CLINICAL TRIALS UNITS FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES: EVALUATION OF THERAPEUTICS FOR NEISSERIA GONORRHOEAE

The Phase I Clinical trial units, through individual contracts with academic centers and organizations that provide resources for the development and implementation of Phase I trials, will investigate therapeutic agents for the treatment of infectious diseases. The units will investigate therapeutic agents for viral (other than HIV), bacterial, fungal and parasitic diseases including NIAID priority biodefense pathogens and emerging and re-emerging diseases. The Phase I units provide an invaluable vehicle for the investigation of new therapeutic and immunomodulatory agents for the treatment of infectious disease.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    N01
  • Administering IC
    AI
  • Application Type
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    4083461
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NIAID:4083461\
  • Funding Mechanism
    Non SBIR/STTR Contracts
  • Study Section
  • Study Section Name
  • Organization Name
    DYNPORT VACCINE COMPANY, LLC
  • Organization Department
  • Organization DUNS
    014130053
  • Organization City
    FREDERICK
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    217024734
  • Organization District
    UNITED STATES